93748-83-5

Upstream product

• 109-83-1 (2-hydroxyethyl)(methyl)amine 
• 393-52-2 2-Fluorobenzoyl chloride 
• 478163-07-4 2-fluorobenzyl methanesulfonate 
• 446-51-5 2-fluorobenzyl alcohol 

Downstream Products

• 478163-09-6 4-(2-(N-(2-fluorobenzyl)-N-methylamino)ethoxy)acetophenone 
• 478163-10-9 tert-butyl 4-[4-(2-(N-(2-fluorobenzyl)-N-methylamino)ethoxy)phenyl]-4-oxobutyrate 
• 478162-56-0 4-[4-(2-(N-(2-fluorobenzyl)-N-methylamino)ethoxy)phenyl]-4-oxobutyric acid 
• 478163-08-5 2-(N-(2-fluorobenzyl)-N-methylamino)ethyl chloride 

Relevant academic research and scientific papers

Compounds for the treatment of metabolic disorders

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

An efficient optical resolution of nitrogen-centered chiral β-hydroxy-tetraalkylammonium salts via complexation with (R)-BINOL

The optical resolution of nitrogen-centered chiral β-hydroxy-tetraalkylammonium bromides is demonstrated by using chiral BINOL as a complexing agent. Determination of the enantiopurities and absolute configurations of the resolved N-chiral tetraalkylammonium salts are described.

Compounds for the treatment of metabolic disorders

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.